Voltar aos Detalhes do Artigo EVALUATION OF THE PROFILE OF ADVERSE EVENT NOTIFICATIONS FOR IVERMECTIN AND NITAZOXANIDE BEFORE AND DURING THE COVID-19 PANDEMIC Baixar Baixar PDF